International

Curaleaf 1st to Secure Registration for Standardized Cannabis Preparations in Spain

The milestone reinforces Curaleaf's leadership in bringing pharmaceutical-grade cannabis products to emerging international markets.

Khalifa Kush Enters 6th International Market as Patience, Diligence Pay Off

Khalifa Kush CEO DJ Saul explains the secret sauce to the celebrity-founded cannabis brand’s expansion efforts, partnerships and overall success.

Tilray Medical Launches in Panama, Expanding Cannabis Patient Access Across Latin America

Tilray Medical's first medical cannabis product in Panama strengthens its international footprint and supports broader access to regulated cannabinoid-based medicines.

Curaleaf Launches Free CPD-Accredited Platform to Close Medical Cannabis Training Gap for UK Health Care Professionals

The company’s education platform delivers a structured learning framework across foundational science, core clinical knowledge and specialist therapeutic areas.

Glass House Brands Completes 1st International Hemp Sale

The California cannabis company completed the sale of smokeable CBD biomass to Europe.

Cannabis Remains Most Widely Used Drug Worldwide, New Report Reveals

The number of people using cannabis has grown 40% in the past decade, according to the United Nations 2026 World Drug Report.

Khalifa Kush Expands Global Footprint With Entry Into Australia’s Medical Cannabis Market

In partnership with Endoca, Khalifa Kush will launch premium flower and edible offerings for Australian patients.

InterCure Initiates Review of US Medical Cannabis Opportunities Following Federal Rescheduling

The company completed the initial closing of its acquisition of Botanico, expanding its international platform with exclusive access to U.S. genetics.

Tilray Medical Germany Launches ARX, a Premium Cannabis Brand Cultivated in Germany

The new brand combines proven genetics, German cultivation expertise and rigorous quality standards to support patients and health professionals.

Village Farms Commences Cultivation in Phase II Facility in Netherlands

The Groningen facility is now fully operational, lining up profitable sales through the remainder of 2026 and beyond.

Canopy Growth Relaunches Tweed Brand in Germany With New MTL Cannabis Strain Lineup

This marks Canopy’s first international release following its MTL acquisition, as it targets rapid growth in Germany’s medical market.

GCNC, Whitney Economics Report Examines Europe's Expanding Role in Global Cannabis Market

The report explores the EU and UK’s medical market growth, international trade, pricing pressure, regulatory evolution and why Europe may shape the industry's next phase.

Page 1 of 67

Next Page